Belimumab, CAS [[356547-88-1]]

Produktübersicht

• Artikelname: Belimumab, CAS [[356547-88-1]]
• Artikelnummer: MCE-HY-P9952
• Hersteller Artikelnummer: HY-P9952
• Alternativnummer: MCE-HY-P9952-100MG,MCE-HY-P9952-50MG,MCE-HY-P9952-25MG,MCE-HY-P9952-1MG,MCE-HY-P9952-10MG,MCE-HY-P9952-5MG
• Hersteller: MedchemExpress
• Kategorie: Antikörper
• Alternative Synonym: LymphoStat B

Produktbeschreibung

Belimumab (LymphoStat B) is a humanized IgG1lambda monoclonal antibody against B-lymphocyte stimulator (BLyS) protein. Belimumab antagonizes BLyS activity in autoimmune diseases and B-lymphocyte malignancies. Belimumab can be used for systemic lupus erythematosus (SLE) research[1][2][3][4]. The component ratio of this product is Active ingredient: Excipients = 1:1.0-1:1.2.

Produkteigenschaften

• Molekulargewicht: (144.54 kDa)
• Reinheit: 99.40
• CAS Nummer: [356547-88-1]
• Target-Kategorie: CD20,TNF Receptor

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Inhibitory Antibodies